Concentrating the Power
of Chemotherapy

Focused on Chemosaturation
Therapy for Cancers in the
Liver

Learn More

Now Approved in Europe, Delcath’s

Working to Provide Hope to
Patients with Cancers in the Liver

Learn More

<
>

For Patients

Our Technology

What Is Chemosaturation Therapy?

See All Technology & Products

Clinical Research

Learn About Our Research Program

Review the Data From Our Published Clinical Trials

More About Our Clinical Research Program

For Physicians

Congresses and Events

Seventh International Symposium on Regional Cancer Therapies
February 18, 2012

See All News & Events

Clinical Bibliography

Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies

Browse Our Clinical Bibliography

For Investors

Investor Events and Webcasts

Delcath Systems, Inc. at Biotechnology Industry Organization (BIO) CEO and Investor Conference
February 14, 2012

Delcath Systems Inc at Lazard Capital Markets Healthcare Conference
November 15, 2011

See All Investor Events and Webcasts

Latest News

February 16, 2012
Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System

February 15, 2012
Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology

See All News & Events

Careers

Delcath never stops looking for talented people to add to our team. Click here to send us your resume.

See All Careers

Newsletter Sign-up